Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Retinopathy of Prematurity
- Intranasal Dexmedetomidine for Pain Management During Screening for Retinopathy of Prematurity
- A Dosing Study of Intravitreal Bevacizumab for Retinopathy of Prematurity
- Intravitreal Ranibizumab Injection for Aggressive Versus Type 1 Prethreshold Retinopathy of Prematurity
- HEMODYNAMIC RESPONSE OTO PAIN DURING RETINOPATHY OF PREMATURITY SCREENING
- Pharmacokinetics and Safety of Dexamethasone Eye Drops in Preterm Infants
- Efficacy and Safety of Mydriatic Microdrops for Retinopathy Of Prematurity Screening
- Ranibizumab Vs Bevacizumab for Type 1 Retinopathy of Prematurity
- Clonidine as Pain Relief During ROP Eye Examinations
- Mother Milk as a Eye Drop & Premature Retinopathy
- Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study
- A Randomized Trial of Low-Dose Bevacizumab vs Laser for Type 1 ROP
- Bevacizumab Treatment For Posterior Zone I ROP
- Efficacy and Safety of Mydriatic Microdrops Compared With Standard Drops for Retinopathy of Prematurity (ROP) Screening: a Pilot Randomized Clinical Trial
- PhaseI/II Investigator-Initiated Trial to Investigate Safety and Efficacy of Ripasudil in Patients With Retinopathy of Prematurity
- Fasudil Eye Drop in Retinopathy Of Prematurity(ROP)
- Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity
- Zinc Supplementation on Very Low Birth Weight Infant
- Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090
- Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy
- Effect of Vitamin E for Prevention of Retinopathy of Prematurity: A Randomized Clinical Trial.
- A Clinical Efficacy and Safety Study of SHP607 in Preventing Chronic Lung Disease in Extremely Premature Infants
- Effects of Early Vitamin A Supplementation on the Risk for Retinopathy of Prematurity in Extremely Preterm Infants
- VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP
- Serum Vascular Endothelial Growth Factor in Infants With Intravitreal Ranibizumab
- Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity
- Oral Propranolol Improve Retinopathy of Prematurity Outcomes in Very Preterm Infants
- Infant-parent Skin-to-skin Contact During Screening for Retinopathy
- A Fatty Acids Study in Preventing Retinopathy of Prematurity
- Rainbow Extension Study
- Safety and Efficacy of Propranolol 0.2% Eye Drops in Treating Retinopathy of Premature: A Pilot Study (DROP-ROP-0.2%)
- Omega-3 LCPUFA Supplementation in Very Low Birth Weight Infants for The Prevention Retinopathy of Prematurity
- Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
- Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)
- RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
- Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)
- Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease
- Safety and Efficacy of Propranolol Eye Drops in Treating Retinopathy of Premature
- Anesthesia for Retinopathy of Prematurity
- Inositol to Reduce Retinopathy of Prematurity
- The Efficacy of Paracetamol in Reducing Pain During Ophthalmological Examination for Retinopathy of Prematurity: a Prospective Randomised Trial
- Topical Betaxolol for the Prevention of Retinopathy of Prematurity
- Proparacaine and Mydriatic Eye Drops
- Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study
- Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
- IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
- Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity
- Study on Effective Mydriasis in Premature Infants
- Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
- Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants
- Use of Pan-Vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)
- Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity
- Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity
- Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
- Vitamin A and Very Low Birthweight Babies (VitAL)
- Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
- Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
- Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
- Surfactant Positive Airway Pressure and Pulse Oximetry Trial